http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111190008-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 2020-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111190008-B |
| titleOfInvention | Application of serum MPO-DNA in prediction of breast cancer prognosis and inhibition of breast cancer distant organ metastasis |
| abstract | The invention discloses an application of a serum MPO-DNA compound in predicting breast cancer prognosis or inhibiting breast cancer distant organ metastasis and a kit, wherein the kit comprises a reagent for detecting the expression quantity of the serum MPO-DNA in a breast cancer patient; in addition, MPO-DNA inhibitors can inhibit metastasis of breast cancer cells. The kit of the invention assists the existing prognosis diagnosis to improve the survival rate of patients; the invention also provides a novel breast cancer treatment scheme. |
| priorityDate | 2020-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.